Carbon ion radiotherapy for skull base chordomas and chondrosarcomas: a systematic review and meta-analysis of local control, survival, and toxicity outcomes Victor M. LuKyle P. O’ConnorJamie J. Van Gompel Topic Review 23 March 2020 Pages: 503 - 513
Awake glioma surgery: technical evolution and nuances Andrew J. GogosJacob S. YoungMitchel S. Berger Topic Review 08 April 2020 Pages: 515 - 524
Inpatient and outpatient case prioritization for patients with neuro-oncologic disease amid the COVID-19 pandemic: general guidance for neuro-oncology practitioners from the AANS/CNS Tumor Section and Society for Neuro-Oncology Rohan RamakrishnaGelareh ZadehManish K. Aghi Topic Review 09 April 2020 Pages: 525 - 529
Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine Daniel C. MoreiraSujatha VenkataramanRajeev Vibhakar Laboratory Investigation 16 March 2020 Pages: 531 - 545
Repolarized macrophages, induced by intermediate stereotactic dose radiotherapy and immune checkpoint blockade, contribute to long-term survival in glioma-bearing mice Alexander M. StessinMariano Guardia ClausiSamuel Ryu Laboratory Investigation 25 March 2020 Pages: 547 - 555
Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1 Matthew GallittoRossana Cheng HeRaymund L. Yong Laboratory Investigation Open access 19 March 2020 Pages: 557 - 566
High expression of estrogen receptor alpha and aromatase in glial tumor cells is associated with gender-independent survival benefits in glioblastoma patients Lisa Stefanie HöniklFriederike LämmerClaire Delbridge Laboratory Investigation Open access 02 April 2020 Pages: 567 - 575
GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma Sascha MarxFabian WilkenNikolai Siebert Laboratory Investigation 03 April 2020 Pages: 577 - 585
RIPK3 is a novel prognostic marker for lower grade glioma and further enriches IDH mutational status subgrouping Guilherme Afonso VergaraGisele Cristine EugenioRicardo Weinlich Laboratory Investigation 28 March 2020 Pages: 587 - 594
In silico analysis of the immunological landscape of pituitary adenomas Jacky T. YeungMatthew D. VeselyDanielle F. Miyagishima Laboratory Investigation 31 March 2020 Pages: 595 - 598
Intratumor injection of CCL21-coupled vault nanoparticles is associated with reduction in tumor volume in an in vivo model of glioma Brittany L. VothPanayiotis E. PelargosIsaac Yang Laboratory Investigation 09 April 2020 Pages: 599 - 605
A matched-pair analysis comparing stereotactic radiosurgery with whole-brain radiotherapy for patients with multiple brain metastases Rami A. El ShafieAylin CelikStefan Rieken Clinical Study 01 April 2020 Pages: 607 - 618
Effect of early radiotherapy initiation and high-dose chemotherapy on the prognosis of pediatric atypical teratoid rhabdoid tumors in different age groups Wan-Chin YangHsiu-Ju YenYi-Wei Chen Clinical Study 28 March 2020 Pages: 619 - 631
Adult primary high-grade spinal glioma: a nationwide analysis of current trends in treatment and outcomes Ravi S. NunnaSyed KhalidAnkit I. Mehta Clinical Study 17 March 2020 Pages: 633 - 641
Diffusion MRI changes in the anterior subventricular zone following chemoradiation in glioblastoma with posterior ventricular involvement Nicholas ChoChencai WangBenjamin M. Ellingson Clinical Study 01 April 2020 Pages: 643 - 652
Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma Andrew SongVoichita Bar-AdWenyin Shi Clinical Study 23 March 2020 Pages: 653 - 661
End-of-life care for glioma patients; the caregivers’ perspective Caroline HertlerGünter EiseleMichael Weller Clinical Study 30 March 2020 Pages: 663 - 669
Incidence of high grade gliomas presenting as radiographically non-enhancing lesions: experience in 111 surgically treated non-enhancing gliomas with tissue diagnosis Daniel G. EichbergLong DiMichael E. Ivan Clinical Study 27 March 2020 Pages: 671 - 679
Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma Paul ManningShadi DaghighiNikdokht Farid Clinical Study 01 April 2020 Pages: 681 - 690
Pre-stereotactic radiosurgery neutrophil-to-lymphocyte ratio is a predictor of the prognosis for brain metastases Lifeng ZhangYanjia HuJing Chen Clinical Study 06 April 2020 Pages: 691 - 700
Incidence of second malignancies in individuals diagnosed with malignant peripheral nerve sheath tumors Lindsay A. WilliamsChristopher L. MoertelErin L. Marcotte Clinical Study 01 April 2020 Pages: 701 - 709
Geographic disparities in access to glioblastoma treatment based on Hispanic ethnicity in the United States: Insights from a national database Victor M. LuAshish H. ShahMichael E. Ivan Clinical Study 31 March 2020 Pages: 711 - 720
Intracranial growing teratoma syndrome (iGTS): an international case series and review of the literature George MichaielDouglas StrotherLucie Lafay-Cousin Clinical Study 15 April 2020 Pages: 721 - 730
The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA) Danielle R. WeidmanSunitha PalasamudramUte Bartels Clinical Study 13 April 2020 Pages: 731 - 736